Germany Develops Corona Vaccine Trials started on Humans

A German pharmaceutical company has developed a vaccine for the coronavirus and started testing it on humans. The BNT162 vaccine has been administered to 12 people since April 23, according to BioNTech, a leading German pharmaceutical company that works with the American company Pfizer.

Read Also: Corona vaccine expected to be ready in November

The German company says it will begin testing the vaccine on a group of 200 people between the ages of 18 and 55 in the next phase. It is to be noted that many companies and institutions around the world, including the German company, are currently working on more than 100 vaccines for the coronavirus, five of which have been tested on humans.

However, experts say it will still take at least a year to develop the safest vaccine for the coronavirus.

 

Newsnblogs

Newsnblogs is a global media company, focusing on business, investing, technology, entrepreneurship, leadership, and lifestyle.

Leave a Comment